Cargando…

Prognostic effect of HER2 evolution from primary breast cancer to breast cancer metastases

PURPOSE: Therapeutic options for breast cancer (BC) treatment are constantly evolving. The Human Epidermal Growth Factor 2 (HER2)-low BC entity is a new subgroup, representing about 55% of all BC patients. New antibody–drug conjugates demonstrated promising results for this BC subgroup. Currently, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Löb, Sanja, Linsmeier, Eva, Herbert, Saskia-Laureen, Schlaiß, Tanja, Kiesel, Matthias, Wischhusen, Jörg, Salmen, Jessica, Kranke, Peter, Quenzer, Anne, Kurz, Florian, Weiss, Claire, Gerhard-Hartmann, Elena, Wöckel, Achim, Diessner, Joachim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349762/ https://www.ncbi.nlm.nih.gov/pubmed/36451043 http://dx.doi.org/10.1007/s00432-022-04486-0

Ejemplares similares

Optimized process quality in certified breast centers through adherence to stringent diagnostic and therapeutic algorithms effects of structural as well as socio-demographic factors on start of therapy
por: Herbert, Saskia-Laureen, et al.
Publicado: (2022)

Predictors of Decreased Quality of Life in Breast Cancer Survivors Five Years After Diagnosis
por: Herbert, Saskia-Laureen, et al.
Publicado: (2023)

Evaluating a novel 3D printed model for simulating Large Loop Excision of the Transformation Zone (LLETZ)
por: Kiesel, Matthias, et al.
Publicado: (2022)

Evaluation of different imaging modalities for axillary lymph node staging in breast cancer patients to provide a personalized and optimized therapy algorithm
por: Diessner, Joachim, et al.
Publicado: (2022)

Evaluating the value of a 3D printed model for hands-on training of gynecological pelvic examination
por: Kiesel, Matthias, et al.
Publicado: (2022)

Psycho-Oncological Care Provision in Highly Distressed Breast Cancer Patients
por: Schlaiss, Tanja, et al.
Publicado: (2023)

Prepubertal Idiopathic Unilateral Gynecomastia: Case Report and Literature Review
por: Herbert, Saskia-Laureen, et al.
Publicado: (2022)

The effects of the COVID-19 pandemic on psychological stress in breast cancer patients
por: Bartmann, Catharina, et al.
Publicado: (2021)

The impact of breast cancer biological subtyping on tumor size assessment by ultrasound and mammography - a retrospective multicenter cohort study of 6543 primary breast cancer patients
por: Stein, Roland Gregor, et al.
Publicado: (2016)

Analysis of microRNAs in Exosomes of Breast Cancer Patients in Search of Molecular Prognostic Factors in Brain Metastases
por: Curtaz, Carolin J., et al.
Publicado: (2022)

Introducing a novel model for simulating large loop excision of the transformation zone (LLETZ) using 3D printing technique
por: Kiesel, Matthias, et al.
Publicado: (2021)

Morphokinetic analysis of early human embryonic development and its relationship to endometriosis resection: a retrospective time-lapse study using the KIDScore™ D3 and D5 implantation data algorithm
por: Herbert, Saskia-Laureen, et al.
Publicado: (2023)

Awareness, offer, and use of psychosocial services by breast cancer survivors in Germany: a prospective multi-centre study
por: Singer, Susanne, et al.
Publicado: (2022)

Implications for surveillance for breast cancer patients based on the internally and externally validated BRENDA-metastatic recurrence score
por: Ebner, Florian, et al.
Publicado: (2023)

Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer
por: Diessner, Joachim, et al.
Publicado: (2016)

BRENDA-Score, a Highly Significant, Internally and Externally Validated Prognostic Marker for Metastatic Recurrence: Analysis of 10,449 Primary Breast Cancer Patients
por: Wischnewsky, Manfred, et al.
Publicado: (2021)

Do Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study
por: Diessner, Joachim, et al.
Publicado: (2016)

Serum-derived factors of breast cancer patients with brain metastases alter permeability of a human blood–brain barrier model
por: Curtaz, Carolin J., et al.
Publicado: (2020)

Anti-Hormonal Therapy in Breast Cancer and Its Effect on the Blood-Brain Barrier
por: Curtaz, Carolin J., et al.
Publicado: (2022)

Inhibition of TGF-β-receptor signaling augments the antitumor function of ROR1-specific CAR T-cells against triple-negative breast cancer
por: Stüber, Tanja, et al.
Publicado: (2020)

Nectin‐2 in ovarian cancer: How is it expressed and what might be its functional role?
por: Bekes, Inga, et al.
Publicado: (2019)

To which extent do breast cancer survivors feel well informed about disease and treatment 5 years after diagnosis?
por: Herbert, S. L., et al.
Publicado: (2020)

Association of social service counseling in breast cancer patients with financial problems, role functioning and employment—results from the prospective multicenter BRENDA II study
por: Dayan, Davut, et al.
Publicado: (2022)

Trastuzumab Biosimilars in the Therapy of Breast Cancer – “Real World” Experiences from four Bavarian University Breast Centres
por: Hester, Anna, et al.
Publicado: (2020)

Targeting of preexisting and induced breast cancer stem cells with trastuzumab and trastuzumab emtansine (T-DM1)
por: Diessner, J, et al.
Publicado: (2014)

A 3D printed model of the female pelvis for practical education of gynecological pelvic examination
por: Kiesel, Matthias, et al.
Publicado: (2022)

Effect of adjuvant radiotherapy in elderly patients with breast cancer
por: Stueber, Tanja Nadine, et al.
Publicado: (2020)

Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages – a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape
por: Montalbán del Barrio, Itsaso, et al.
Publicado: (2016)

Establishment of the SIS scaffold-based 3D model of human peritoneum for studying the dissemination of ovarian cancer
por: Herbert, Saskia-Laureen, et al.
Publicado: (2022)

AGO Algorithms for the Treatment of Breast Cancer: Update 2021
por: Schneeweiss, Andreas, et al.
Publicado: (2021)

Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients
por: Sassen, Andrea, et al.
Publicado: (2008)

Post-Neoadjuvant Treatment in HER2-Positive Breast Cancer: Escalation and De-Escalation Strategies
por: Krawczyk, Natalia, et al.
Publicado: (2022)

Update Breast Cancer 2020 Part 4 – Advanced Breast Cancer
por: Tesch, Hans, et al.
Publicado: (2020)

Role of Renin-Angiotensin-System in Human Breast Cancer Cells: Is There a Difference in Regulation of Angiogenesis between Hormone-Receptor Positive and Negative Breast Cancer Cells?
por: Herr, Daniel, et al.
Publicado: (2019)

Update Breast Cancer 2020 Part 3 – Early Breast Cancer
por: Huober, Jens, et al.
Publicado: (2020)

ESE-1/ELF3 mRNA expression associates with poor survival outcomes in HER2(+) breast cancer patients and is critical for tumorigenesis in HER2(+) breast cancer cells
por: Kar, Adwitiya, et al.
Publicado: (2017)

The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers
por: Majumder, Avisek, et al.
Publicado: (2021)

Breast Cancer and Her-2/Neu
por: Sherwood, Roy
Publicado: (2005)

Target HER four in breast cancer?
por: Brockhoff, Gero
Publicado: (2019)

Circulating MicroRNAs and Blood-Brain-Barrier Function in Breast Cancer Metastasis
por: Curtaz, Carolin J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mn1rju9iupf7lrh4mrn1s6afoi